Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
21 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/21/2933622/0/en/PharmaTher-s-Sairiyo-Therapeutics-Announces-Independent-Screening-Identifying-Cepharanthine-s-Potential-to-Bind-to-Monkeypox-Mpox-Proteins.html
19 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/19/2932052/0/en/PharmaTher-s-Sairiyo-Therapeutics-Receives-Approval-to-Initiate-a-Phase-1-Human-Clinical-Trial-of-PD-001-Reformulated-Cepharanthine.html
15 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/15/2882391/0/en/PharmaTher-s-Sairiyo-Therapeutics-Submits-Clinical-Trial-Application-for-Phase-1-Study-of-Patented-Reformulated-Cepharanthine.html
01 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/01/2873176/0/en/PharmaTher-s-Sairiyo-Therapeutics-Completes-Clinical-and-Regulatory-Package-for-Phase-1-Study-of-Patented-Reformulated-Cepharanthine.html
21 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/21/2832853/0/en/PharmaTher-s-Sairiyo-Therapeutics-Inc-Advances-Clinical-Development-of-Patented-Reformulated-Cepharanthine-for-Phase-1-Study-in-Australia.html
https://www.globenewswire.com/news-release/2023/07/18/2706302/0/en/PharmaTher-Announces-Positive-Research-Results-for-PharmaPatch-with-N-N-dimethyltryptamine-DMT-and-Strategic-Investment-into-Sairiyo-Therapeutics.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?